Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CrossMark
Data Policies
CASE REPORT
Late relapse of testicular tumour at 23 years invading the ischium with pulmonary involvement and thoracic - abdominal adenopathy. Case report
1
University Clinic of Urology, Alexandroupoli
University Hospital
2
2nd Clinic of Thoracic Surgery, Sotiria General
Hospital, Athens
Pneumon 2010;23(1):107-110
KEYWORDS
ABSTRACT
Late relapse of testicular germ cell tumour is uncommon, especially with skeletal metastases. It appears that late relapse of non-seminomatous germ cell tumours presents with more aggressive biological features and is clinically distinct from early relapse. This report describes the case of a non-seminomatous germ cell tumour which recurred 23 years after the initial diagnosis and treatment. A 52-year-old man developed an ischial bone osteolytic mass which was discovered during investigation of severe pain in the hip joint.
REFERENCES (16)
2.
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 2008;53(3):497-513. Epub 2007 Dec 26.
3.
Dieckmann KP, Albers P, Classen J, et al. Late relapse of testicular germ cell neoplasms: A descriptive analysis of 122 cases. J Urol 173: 824-829, 2005.
4.
Oldenburg J, Alfsen GC, Waehre H, Fossε SD. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer 2006;94(6):820-7.
5.
Sugimura J, Foster RS, Cummings OW, et al. Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis. Clin Cancer Res 2004;10(7):2368-78.
6.
Shahidi M, Norman AR, Dearnaley DP, Nicholls J, Horwich A, Huddart RA. Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management. Cancer 2002;95(3):520-30.
7.
Gerl A, Lamerz R, Mann K, Clemm C, Wilmanns W. Is serum tumor marker half-life a guide to prognosis in metastatic nonseminomatous germ cell tumors? Anticancer Res 1997;17(4B):3047-9.
8.
Borge N, Fossε SD, Ous S, Stenwig AE, Lien HH. Late recurrence of testicular cancer. J Clin Oncol 1988; 6(8):1248-53.
9.
Baniel J, Foster RS, Gonin R, Messemer JE, Donohue JP, Einhorn LH. Late relapse of testicular cancer. J Clin Oncol 1995;13(5):1170-6.
10.
Ravi R, Oliver RT, Ong J, et al. A single-centre observational study of surgery and late malignant events after chemotherapy for germ cell cancer. Br J Urol 1997;80(4):647-52.
11.
Rutherford EE, Ferguson JL, Geldart TR, Mead GM, Smart JM, Tung KT. Late relapse of metastatic non-seminomatous testicular germ cell tumours.Clin Radiol 2006;61(11):907-15. Review.
12.
Carver BS, Motzer RJ, Kondagunta GV, Sogani PG, Sheinfeld J. Late relapse of testicular germ cell tumors. Urol Oncol 2005;23(6):441-5. Review.
13.
Lipphardt ME, Albers P. Late relapse of testicular cancer. World J Urol 2004;22(1):47-54. Epub 2004 Apr 3. Review.
14.
George DW, Foster RS, Hromas RA, et al. Update on late relapse of germ cell tumor: a clinical and molecular Analysis J Clin Oncol 2003;21(1):113-22..
15.
Hartmann JT, Gauler T, Metzner B, et al. German Testicular Cancer Study Group. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. J Clin Oncol 2007;25(36):5742-7.
16.
Kondagunta GV, Bacik J, Donadio A, et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors J Clin Oncol 2005;23(27):6549-55.
| eISSN: | 1791-4914 |
| ISSN: | 1105-848X |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
